skip to the main content

Free Anti-Infliximab

Detecting the development of Anti-drug antibodies (ADAs) against Infliximab in patients being treated with Infliximab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 12 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

  • CE

Available Instruments

About Using Reagent

  • Sample Types

    Whole blood, Serum
  • Reaction Time

    12 mins
  • Detection Range

    4-250 AU/mL
  • Intended Use

    Semi-quantitative determination of free antibodies to infliximab in human whole blood/serum

In Your Medical Field

AFIAS Free Anti-Infliximab detects anti-drug antibodies against Infliximab in just 12 minutes using a small amount of blood. It provides valuable insights into patients’ response to the treatment of Infliximab.